glp-1/gip agonists Frontiers Major physiological roles of GLP-1

Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimers Disease: Study Protocol for a Randomised Controlled Trial (ELAD Study). Trials, vol

Additional mechanistic studies will however be necessary to fully understand the molecular action of tirzepatide

Available from FDA Website: Wegovy prescribing information/package insert

June 25, 2025

Liraglutide, which has been approved for reducing the risk of T2MD, has also been found to reduce the risk of major cardiovascular events in adults with established CVDs ( Table 1 Classification of GLP-1RAs

Efficacy and safety of exenatide once weekly versus liraglutide in subjects with type 2 diabetes (DURATION-6): a randomised, open-label study [abstract 75]